House lawmakers frustrated with EpiPen CEO’s answers

By Robert King

Published September 22, 2016 1:37am ET

House lawmakers frustrated with EpiPen CEO’s answers — "Frankly, you might as well take the fifth too, with the kind of information that we got here today," Rep. Elijah Cummings, D-Md., said at the conclusion of a House Oversight Committee hearing on Mylan's price hike for the EpiPen. (AP Photo/Pablo Martinez Monsivais) | Pablo Martinez Monsivais

Rep. Elijah Cummings, D-Md., remembers when former pharma CEO Martin Shkreli came to Congress in February to answer for raising the price of an antimalarial drug by 5,000 percent.

Shkreli didn’t answer any questions after invoking his Fifth Amendment right against self-incrimination because of federal securities fraud charges.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

House lawmakers frustrated with EpiPen CEO’s answers

Recommended Stories

After backlash, Mylan to lower EpiPen cost to some patients

FDA approves first generic competitor for EpiPen

What Mylan’s CEO learned from the EpiPen outrage

Full midterm coverage.Deeper analysis.

Tag: